Injectable Drug Delivery Market 2023 Segmentation and Regional Analysis by 2032

The global injectable drug delivery market size was valued at USD 561.0 billion in 2021 and is projected to reach up to 1,223.0 million in 2030, with a CAGR of 9.0% in the forecasted period.

The rising prevalence of cancer, increasing incidences of chronic diseases are driving the market growth. Moreover, the rise in biologics market is also among the prominent factors for the market growth in the forecasted period.

One of the substantial factors driving the growth of global injectable drug delivery market is rising prevalence of cancer. As per the International Agency for Research on Cancer, 1 in 5 individuals will develop cancer during their lifetime by December 2020, with 1 in 8 men and 1 in 11 women dying from the disease globally. According to the International Agency for Research, cancer cases and deaths will grow up to 19.3 million cases and 10 million deaths in 2020, up from 18 million cases and deaths in 2018. Moreover, the major market players are concentrating on new product development and launches. For instance, the U.S. Food and Drug Administration approved Apretude for pre-exposure prophylaxis to lower the risk of sexually acquired HIV in adults weighing at least 35 kg in December 2021.

The COVID-19 pandemic has both valuable and negative impacts on the healthcare sector. The escalating COVID-19 patient populace is placing strain on healthcare systems. Due to the improved demand for medical things such as injections and pre-filled syringes, manufacturers have enhanced their making capacity to keep up with demand. Additionally, the government around the globe is backing towards the growth of injectable drugs delivery market. The government is profoundly investing for the growth and launch of novel injectable drugs delivery in the market.

Download a Sample Copy of Injectable Drug Delivery Market: https://analyticsmarketresearch.com/sample-request/injectable-drug-delivery-market/21645/

Type Insights
The devices segment accounted largest revenue share in 2021. The growing prevalence of chronic disorders is leading to an increase in overall syringe practice, predominantly disposable syringes. The cardiovascular illnesses, diabetes, and obesity have been found to be leading causes of death from chronic disorders. As populace surge is believed to be the critical factor in emerging nations, this is likely to have the highest impact all around the world.

Therapeutic Application Insights
The auto-immune diseases segment hold the largest revenue share in 2021. The immune system bouts and terminates its own body tissue in autoimmune disorders. The diabetes, rheumatoid arthritis, lupus, and other auto-immune diseases are amongst the most frequent diseases. Anti-inflammatory medicines, immune suppressants, and other medicines have been approved to treat auto-immune diseases.

The oncology segment is fastest developing segment of the injectable drugs delivery market in 2021. The rising prevalence of cancer is fuelling the growth of the segment. As per the data of the American Cancer Society, by 2020, there will be around 1,806,590 cancer patients in the U.S. alone, up 31% from 2010.

Distribution Channel Insights
The hospitals segment holds the maximum share in the injectable drugs delivery market in 2021. This is attributed to an increase in the patient's admitted to hospitals with acute and chronic wounds. Moreover, growth of the segment is also being compelled by the surge in the number of individual clinics in developed and emerging countries.

The retail pharmacy stores segment is predicted to show substantial growth over the forecasted period. The retail pharmacies trade pharmaceutical medications and drugs. These stores provide generic and branded medications, and other pharmaceutical supplies. The increasing preference of patients for purchasing injectable drugs delivery from these stores is boosting the growth of the segment.

Regional Insights
North America is expected to dominate the injectable drugs delivery market in 2021. The rise of injectable drugs delivery market in North America region is being accredited to the rising prevalence of numerous disorders. As per the Alzheimer's Association, around 6.2 million Americans aged 65 and older will have Alzheimer's disease by 2020. There are around 3.8 million women and 2.4 million men among those patients. Furthermore, increasing adoption of approaches by market players are also aiding the growth of North America injectable drugs delivery market. For instance, in July 2020, Piramal Critical Care collaborated with Medivant Healthcare, to answer the substantial shortage of injectable medications in hospitals across the nation.

Increased R&D investments, government initiatives to increase awareness about chronic diseases, and rise in healthcare spending are some of the factors that are driving the growth of the injectable drug delivery market in these regions.

Europe, is predicted to grow at the fastest rate during the forecasted period. The UK holds the largest share in the injectable drugs delivery market in Europe region. The Europe injectable drugs delivery market is attributed to the factors such as the rise of the biologics market, increasing incidence of chronic disorders, and the growing demand for self-injection devices are all contributing to this trend. The other factors impelling the growth of injectable drugs delivery market in Europe region are escalating disposable income, growing number of partnerships, and increasing awareness about safety and comfort.
However, a considerably large patient pool in the Asia Pacific region will provide probable growth openings for players in the injectable drug delivery market.

Key Companies Insights
Key players are aiming on their technological partnerships, collaborations, and merger & acquisitions strategies to gain an economical edge and grow their product portfolio & business footmarks. The Covid-19 pandemic hindered the healthcare systems worldwide and driven the market players to transform products for unexploited opportunities.

Some of the key players operating in the global injectable drug delivery market include:
• BD
• Pfizer Inc.
• Teva Pharmaceuticals Industries Ltd.
• Eli Lilly and Company
• Baxter International, Inc.
• Sandoz
• Terumo
• Schott AG
• Gerresheimer
• Ypsomed
• Bespak
• B. Braun Melsungen
• Other players

Direct Purchase Injectable Drug Delivery Market Research Report: https://analyticsmarketresearch.com/purchase/injectable-drug-delivery-market/21645/?license=single

Some of the Recent Developments:
• In 2016, Biocon launched its disposable pen product in Japan, which will be distributed by its partner Fujifilm Pharma throughout the country.
• In March 2015, BD bought CareFusion Corporation to expand its capabilities and improve drug management and patient safety. In the same year, BD purchased CRISI Medical Systems, a medical technology business, in order to improve the efficiency of drug delivery via IV injectable. BD has a worldwide presence in 50 nations, allowing it to maintain its position in the global market.
• In June 2020, Pfenex Inc. announced that Alvogen, its commercialization partner, had launched Teriparatide Injection in the U.S. for a variety of indications, including postmenopausal women with osteoporosis who are at high risk of broken bones.
• In 2014, Terumo Corporation partnered with Ypsomed Group. The organization combined their prefillable polymer syringe, PLAJEX, with YpsoMate as a result of this agreement. This aided the corporation in strengthening their syringe product offerings.
• In 2015, Sanford-Burnham Medical Research Institute and Eli Lilly and Company formed a partnership to discover immunological therapeutics for inflammatory bowel disorder, lupus, and autoimmune diseases. The expertise of both institutions will be pooled to discover novel treatments for these disorders.

Segments
By Type
• Devices
o Conventional Injectables
o Pre-Filled Syringes
o Auto-Injectors
o Pen-Injectors
• Formulations

By Formulation Packaging
• Ampules
• Vials
• Cartridges
• Bottles

By Therapeutic Application
• Auto-immune diseases
• Hormonal Disorders
• Orphan Diseases
• Oncology
• Others

By Usage Pattern
• Curative Care
• Immunization
• Other

By Site of Administration
• Skin
• Circulatory/Musculoskeletal
• Organs
• Central Nervous System

By Distribution Channel
• Hospitals & Clinics
• Retail Pharmacy Stores
• Others

By Facility of Use
• Hospitals & Clinics
• Home Care Settings
• Other

By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o ASEAN
• Latin America
o Brazil
o Argentina
o Colombia
• MEA
o South Africa
o Saudi Arabia
o UAE
o Egypt

Read More: https://analyticsmarketresearch.com/reports/injectable-drug-delivery-market/21645/

Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?

Contact US:
Analytics Market Research
99 WALL STREET, #2124 NEW YORK, NY 10005
Phone: +1(650)-666-4592
Email: sales@analyticsmarketresearch.com
Web: https://analyticsmarketresearch.com/

About US:
Analytics Market Research is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.

Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. Analytics Market Research is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.

This release was published on openPR.